• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

IsoRay

Isoray grows sales 19% in Q2 results

February 9, 2022 By Danielle Kirsh

Isoray (NYSE:ISR) posted second-quarter results this week that were in line with estimates on Wall Street. The Richland, Washington–based brachytherapy company reported losses of $1.6 million, or -1¢ per share, on sales of $2.82 million for the three months ended Dec. 31, 2021, for a sales growth of 19.4% compared with Q2 2021. Earnings per […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: IsoRay

Ex-Medtronic CFO Ellis joins Inspire Medical board | Personnel Moves, August 2, 2019

August 2, 2019 By Brad Perriello

Inspire Medical Systems last week named Gary Ellis, the former CFO at Medtronic (NYSE:MDT), to its board of directors effective immediately. Minneapolis-based Inspire Medical also said that Amzak Health managing partner Joyce Erony left the board effective yesterday. Ellis spent 27 years at Medtronic before retiring in 2016. “On behalf of the entire Inspire board […]

Filed Under: Business/Financial News, Featured Tagged With: AliveCor, apyxmedical, Cardiovascular Systems Inc., General Electric, Inspire Medical Systems Inc., Iradimed Corp, IsoRay, Medical Device Innovation Consortium, NeuroPace, T2 Biosystems Inc.

Medicare might cover more cutting-edge medtech and pay more for it, too

July 30, 2019 By Nancy Crotti

The Centers for Medicare and Medicaid Services (CMS) said today it wants to give Medicare patients better access to cutting-edge medical devices, and that it’s willing to pay more for them beginning in fiscal year 2020. In its proposed rule, CMS said it might pay more for “certain transformative new devices” for inpatients through a […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Medicare, News Well, Regulatory/Compliance Tagged With: Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CivaTech Oncology Inc., Claret Medical Inc., FDA, GT Medical Technologies, IsoRay, Johnson and Johnson, Procept BioRobotics, Respicardia, TherOx Inc, Zoll Medical

Owens & Minor taps former Thermo Fisher CCO Pesicka as prez, CEO | Personnel Moves – February 27, 2019

February 27, 2019 By Fink Densford

Owens & Minor (NYSE:OMI) said this month that it named former Thermo Fisher Scientific chief commercial officer Edward Pesicka as its new prez & CEO, effective March 4. Pesicka will replace interim prez & CEO Robert Sledd, who will continue to serve as board chair, the Richmond, Va.-based company said. Prior to his position as chief […]

Filed Under: Business/Financial News, Featured Tagged With: AliveCor, Anaconda Biomed, cathworks, cirtronics, Deerfield Management, IsoRay, Magnolia Medical Technologies, mcginleyorthopedics, Owens and Minor, SurModics Inc., Thermo Fisher Scientific, Xtant Medical, Zimmer Biomet

GT Medical lands $10m Series A for IsoRay’s GammaTile

January 31, 2019 By Brad Perriello

GT Medical Technologies said today that it landed a $10 million Series A round for the GammaTile brachytherapy it co-developed with IsoRay (NYSE:ISR) to treat brain tumors. Richland, Wash.-based IsoRay and the Barrow Neurological Institute formed GT Medical to develop the technology to embed Cesium-131 brachytherapy seeds in collagen tiles to treat malignant meningioma, according to regulatory filings, […]

Filed Under: Featured, Funding Roundup, Radiosurgery/Radiation therapy, Wall Street Beat Tagged With: GT Medical Technologies, IsoRay

Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018

December 12, 2018 By Fink Densford

Sanuwave said late last month that it lifted acting CEO and board chair Kevin Richardson to a permanent position in the corner office. Richardson joined the Suwanee, Ga.-based company in 2009 as board chair, and has served as acting CEO since 2014. He also served as managing partner of investment management firm Prides Capital from […]

Filed Under: Business/Financial News, Featured Tagged With: Bose Corp., Bristol-Myers Squibb Co., Common Sensing, glympsebio, INSIGHTEC, Insulet, IsoRay, Merck, novadipbiosciences, Owens and Minor, rmsmedical, Sanuwave, Visioneering Technologies, Zimmer Biomet

IsoRay inks $8m private placement deal

July 11, 2018 By Fink Densford

IsoRay (NYSE:ISR) has inked a private placement deal worth approximately $8.3 million, according to an SEC filing posted this week. Through the deal, Richland, Wash.-based IsoRay is floating 11 million shares of common stock at 75¢ per share with several institutional and accredited investors, according to the filing. The company said it will also offer unregistered […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: IsoRay

IsoRay wins FDA nod for GammaTile brain tumor treatment

July 10, 2018 By Fink Densford

IsoRay (NYSE:ISR) said today it won FDA 510(k) clearance for its GammaTile brachytherapy technology designed for treating recurrent brain tumors. The Richland, Wash.-based company’s GammaTile is a radiation system using Cesium-131 radiation seeds embedded in a collagen ’tile’ which is designed to be placed in surgical margins at the time of surgery. IsoRay said it had […]

Filed Under: 510(k), Food & Drug Administration (FDA), Neurological, Oncology, Regulatory/Compliance Tagged With: GT Medical Technologies, IsoRay

Dr. Gawande tapped to lead Amazon-JPM-Berkshire health play | Personnel Moves – June 21, 2018

June 21, 2018 By Fink Densford

The joint healthcare venture between Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan Chase said this week it named Brigham and Women’s Hospital surgeon, New Yorker magazine staff writer and bestselling author Dr. Atul Gawande as its CEO, effective July 9. The joint venture said that the newly formed company will be headquartered in Boston, and will operate […]

Filed Under: Business/Financial News Tagged With: AirXpanders, Amazon, Avantis Medical Systems Inc., Berkshire Hathaway, Boston Scientific, CHF Solutions Inc., Corindus Vascular Robotics, Haemonetics, Intuitive Surgical, IsoRay, JP Morgan Chase, medicen, Medtronic, Merz, MRI Interventions, Pivot Medical, Stimwave

Zimmer Biomet prez, CEO Dvorak unexpectedly resigns | Personnel Moves, July 12, 2017

July 12, 2017 By Fink Densford

Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search […]

Filed Under: Business/Financial News Tagged With: Abiomed, Accuray Inc., Amendia, Boston Scientific, C.R. Bard, Cochlear Ltd., conformis, GE Healthcare, InVivo Corp., IsoRay, Johnson and Johnson, Lidco, Lumicell, Neurometrix, Philips, portal instruments, RenalGuard Solutions, Sanofi-Aventis, Spinal Elements, stjudemedical, Stryker, TherOx Inc, Zimmer Biomet

FDA requests more info on IsoRay’s GammaTile

July 6, 2017 By Fink Densford

IsoRay (NYSE:ISR) said today that the FDA requested additional data on the company’s pending 510(k) application for its GammaTile radiation therapy system. The Richland, Wash.-based company’s GammaTile is a radiation system using Cesium-131 radiation seeds embedded in a collagen ’tile’ which is designed to be placed in surgical margins at the time of surgery. “This is […]

Filed Under: Food & Drug Administration (FDA), Oncology Tagged With: IsoRay

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy